US Broker Ratings

Cytokinetics, Incorporated (CYTK) Stock Analysis: Potential Upside of Nearly 95% as Biotech Innovates Muscle Treatments

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with a promising portfolio of muscle activators and inhibitors aimed at treating debilitating diseases. The..

Ascendis Pharma A/S (ASND) Stock Analysis: 35% Potential Upside Attracts Buy Ratings

Ascendis Pharma A/S (NASDAQ: ASND) is capturing the attention of the investment community, offering a tantalizing potential upside of 35.11% according to analysts’ projections. Based in..

Biogen Inc. (BIIB) Stock Analysis: Unveiling a 37.77% Potential Upside Amidst a Robust Neurological Portfolio

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, remains a compelling focus for investors seeking exposure to the drug manufacturing industry. With a market..

GSK plc (GSK) Stock Analysis: Healthcare Giant with 14.90% Upside Potential

GSK plc (GSK), a stalwart in the healthcare sector, commands significant investor attention due to its robust portfolio and promising growth trajectory. Traded on the London..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: High ROE and Strategic Growth in the Healthcare Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare diagnostics and research industry, continues to capture investor attention with its substantial market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Evaluating a 15% Upside Potential

GE HealthCare Technologies Inc. (NYSE: GEHC), a prominent player in the healthcare sector, stands out as an intriguing investment opportunity for discerning investors. With a market..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 33% Potential Upside in Healthcare Innovation

Bruker Corporation (NASDAQ: BRKR) stands as a key player in the healthcare sector, carving out a significant niche within the medical devices industry. Based in the..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Challenges with Resilient Product Offerings

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..

Globus Medical, Inc. (GMED) Stock Analysis: Unpacking a 51% Potential Upside in the Medical Device Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the medical devices industry, has been capturing investor attention with its compelling growth potential and robust product..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 46% Potential Upside in the Healthcare Sector

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the healthcare sector, has long been a staple in the drug manufacturing industry, particularly in the..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring Growth Potential Amidst Biotech Innovations

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, with a market capitalization of $118.08 billion. Known for its innovative treatments..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 30% Upside Potential in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector with its innovative approaches to treating chronic and life-threatening diseases. This biotechnology company, with a..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a 30% Potential Upside Amid Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) is a noteworthy player in the healthcare plans industry, capturing the attention of investors with its innovative approach and substantial growth..

Cencora, Inc. (COR) Investor Outlook: A Healthcare Giant with 10.34% Upside Potential

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, presents a compelling case for investors with its robust presence in the healthcare sector, specifically within the..

Integer Holdings Corporation (ITGR) Stock Analysis: Assessing the 32% Upside Potential for Investors

Integer Holdings Corporation (NASDAQ: ITGR), a prominent player in the healthcare sector, is drawing attention from investors due to its robust growth potential and strategic positioning..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 27.98% Potential Upside Amidst Market Challenges

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is making waves with its promising potential for a 27.98% upside, according to the..

Solventum Corporation (SOLV): Investor Outlook with a 12.12% Potential Upside

Solventum Corporation (SOLV), a burgeoning entity in the healthcare sector, has captured investor attention with its diverse portfolio and potential for growth. With a market capitalization..

Repligen Corporation (RGEN) Stock Analysis: A 56% Potential Upside Amid Strong Buy Ratings

Repligen Corporation (NASDAQ: RGEN) is garnering significant attention from investors, thanks to its robust presence in the healthcare sector as a leading developer of bioprocessing technologies...

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A 7.1% Potential Upside in the Healthcare Sector

iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading player in the healthcare sector specializing in digital medical devices, has emerged as a key innovator in the field..

Alkermes plc (ALKS) Stock Analysis: A 40% Upside Potential Beckons Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the specialized pharmaceutical sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. As a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds